Browse 11 Pharmaceutical companies funded by Almi Invest. See funding amounts, founder contacts, and investment details.
Dicot Pharma, focused on drug discovery and development of a modern potency drug treating erectile dysfunction better than existing drugs.
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.
TIRmed Pharma develops drug candidates addressing major clinical needs.
LipUm operates as a biotechnology company that offers anti-inflammatory drugs.
Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC).
Umecrine Cognition is a developer of pharmaceutical products to treat cognitive neurological disorders.
PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.
Pila Pharma is a TRPV1-platform focused company developing oral treatments for type-2 diabetes, obesity, and pain.
Fluicell is one of the manufacturers of fluid platforms for multifunctional pipettes.
Abarceo Pharma has identified a novel diabetes target located on beta cells and a novel mechanism of action enabling a therapeutic.
Empe Diagnostics develops diagnostic solutions for infectious diseases with a special focus on antimicrobial resistance.
View all companies funded by Almi Invest across every industry and funding stage.
View Full Almi Invest Portfolio